Literature DB >> 12218130

Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus.

Bregje Mommaas1, Janine Kamp, Jan-Wouter Drijfhout, Nico Beekman, Ferry Ossendorp, Peter Van Veelen, Joke Den Haan, Els Goulmy, Tuna Mutis.   

Abstract

The polymorphic minor histocompatibility Ag HA-1 locus encodes two peptides, HA-1(H) and HA-1(R), with a single amino acid difference. Whereas the immunogenicity of the HA-1(R) allele has not yet been shown, the nonameric HA-1(H) peptide induces HLA-A2-restricted cytotoxic T cells in vivo and in vitro. It is not known whether the mHag HA-1(H) or HA-1(R) associates with other HLA class I molecules. Therefore, the polymorphic regions of both HA-1 alleles were analyzed to identify HLA class I binding peptides that are properly processed by proteasomal degradation. Peptide binding analyses were performed for all nonameric HA-1(H/R) peptides for binding to nine HLA class I molecules with >10% prevalence in the Caucasian population and for seven nonameric/decameric HA-1(H/R) peptides predicted to bind to HLA-A3, -B14, and -B60. Only the nonameric KECVL(H)/(R)DDL and decameric KECVL(H)/(R)DDLL peptides showed strong and stable binding to HLA-B60. In vitro digestion of 29-aa-long HA-1 peptides by purified 20S proteasomes revealed proper cleavage at the COOH termini of both HLA-B60 binding HA-1(H) and HA-1(R) peptides. In subsequent analyses, dendritic cells pulsed with the nonameric HA-1(R) peptide did not induce CTLs that recognize the natural HLA-B60/HA-1(R) ligand. In contrast, dendritic cells pulsed with the nonameric HA-1(H) peptide induced IFN-gamma-secreting T cells specific for the natural HLA-B60/HA-1(H) ligand in three HLA-B60(+) HA-1(RR) individuals, demonstrating the immunogenicity of the HLA-B60/HA-1(H) ligand. In conclusion, this study shows a novel HLA-B60-restricted T cell epitope of the minor histocompatibility Ag HA-1 locus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218130     DOI: 10.4049/jimmunol.169.6.3131

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus.

Authors:  Olivia J Holland; Caitlin Linscheid; Herbert C Hodes; Traci L Nauser; Melissa Gilliam; Peter Stone; Larry W Chamley; Margaret G Petroff
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

2.  Computational prediction of cleavage using proteasomal in vitro digestion and MHC I ligand data.

Authors:  Yu-feng Lu; Hao Sheng; Yi Zhang; Zhi-yang Li
Journal:  J Zhejiang Univ Sci B       Date:  2013-09       Impact factor: 3.066

Review 3.  Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation.

Authors:  Jenny Zilberberg; Rena Feinman; Robert Korngold
Journal:  Biol Blood Marrow Transplant       Date:  2014-11-20       Impact factor: 5.742

4.  Trophoblast expression of the minor histocompatibility antigen HA-1 is regulated by oxygen and is increased in placentas from preeclamptic women.

Authors:  C Linscheid; E Heitmann; P Singh; E Wickstrom; L Qiu; H Hodes; T Nauser; M G Petroff
Journal:  Placenta       Date:  2015-06-06       Impact factor: 3.481

Review 5.  Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses.

Authors:  Xin Feng; Kwok Min Hui; Hashem M Younes; Anthony G Brickner
Journal:  Trends Immunol       Date:  2008-10-25       Impact factor: 16.687

6.  Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation.

Authors:  Persis P Wadia; Marc Coram; Randall J Armstrong; Michael Mindrinos; Atul J Butte; David B Miklos
Journal:  Blood       Date:  2010-01-06       Impact factor: 22.113

7.  Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby.

Authors:  Tse-Ching Chen; Herman Waldmann; Paul J Fairchild
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

8.  C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.

Authors:  Scott S Tykodi; Nobuharu Fujii; Nathalie Vigneron; Sharon M Lu; Jeffrey K Mito; Maureen X Miranda; Jeffrey Chou; Lilien N Voong; John A Thompson; Brenda M Sandmaier; Peter Cresswell; Benoît Van den Eynde; Stanley R Riddell; Edus H Warren
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

Review 9.  Minor histocompatibility antigens and the maternal immune response to the fetus during pregnancy.

Authors:  Caitlin Linscheid; Margaret G Petroff
Journal:  Am J Reprod Immunol       Date:  2013-02-08       Impact factor: 3.886

Review 10.  Targeting alloreactive donor T-cells to hematopoietic system-restricted minor histocompatibility antigens to dissect graft-versus-leukemia effects from graft-versus-host disease after allogeneic stem cell transplantation.

Authors:  Tuna Mutis
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.